{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:39:43Z","timestamp":1761237583416},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00347-008-1789-9","type":"journal-article","created":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T08:43:27Z","timestamp":1228121007000},"page":"1101-1107","source":"Crossref","is-referenced-by-count":9,"title":["Pathogenese der Retinopathia praematurorum","Pathogenesis of retinopathy of prematurity"],"prefix":"10.1007","volume":"105","author":[{"given":"M.","family":"Heckmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,3]]},"reference":[{"key":"1789_CR1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.105.2.295","volume":"105","author":"Supplemental","year":"2000","unstructured":"Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial (2000) I: primary outcomes. Pediatrics 105(2): 295\u2013310","journal-title":"Pediatrics"},{"key":"1789_CR2","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","volume":"92","author":"Aiello","year":"1995","unstructured":"Aiello LP, Pierce EA, Foley ED et al. (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A 92(23): 10457\u201310461","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1789_CR3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/ICU.0b013e3282f0ca54","volume":"18","author":"Andreoli","year":"2007","unstructured":"Andreoli CM, Miller JW (2007) Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 18(6): 502\u2013508","journal-title":"Curr Opin Ophthalmol"},{"key":"1789_CR4","first-page":"359","volume":"100","author":"Ashton","year":"1980","unstructured":"Ashton N (1980) Oxygen and the retinal blood vessels. Trans Ophthalmol Soc U K 100(3): 359\u2013362","journal-title":"Trans Ophthalmol Soc U K"},{"key":"1789_CR5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00417-005-0203-4","volume":"244","author":"Balogh","year":"2006","unstructured":"Balogh A, Derzbach L, Vannay A, Vasarhelyi B (2006) Lack of association between insulin-like growth factor I receptor G(+3174)A polymorphism and retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 244(8): 1035\u20131038","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1789_CR6","doi-asserted-by":"crossref","unstructured":"Banyasz I, Bokodi G, Vannay A et al. (2006) Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity. Curr Eye Res 31(7-8): 685\u2013690","DOI":"10.1080\/02713680600801123"},{"key":"1789_CR7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","volume":"10","author":"Chen","year":"2007","unstructured":"Chen J, Smith LE (2007) Retinopathy of prematurity. Angiogenesis 10(2): 133\u2013140","journal-title":"Angiogenesis"},{"key":"1789_CR8","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","volume":"13","author":"Connor","year":"2007","unstructured":"Connor KM, SanGiovanni JP, Lofqvist C et al. (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 13(7): 868\u2013873","journal-title":"Nat Med"},{"key":"1789_CR9","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1167\/iovs.03-1303","volume":"45","author":"Cooke","year":"2004","unstructured":"Cooke RW, Drury JA, Mountford R, Clark D (2004) Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci 45(6): 1712\u20131715","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1789_CR10","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(95)92475-2","volume":"346","author":"Cunningham","year":"1995","unstructured":"Cunningham S, Fleck BW, Elton RA, McIntosh N (1995) Transcutaneous oxygen levels in retinopathy of prematurity. Lancet 346(8988): 1464\u20131465","journal-title":"Lancet"},{"key":"1789_CR11","first-page":"4275","volume":"41","author":"Cunningham","year":"2000","unstructured":"Cunningham S, McColm JR, Wade J et al. (2000) A novel model of retinopathy of prematurity simulating preterm oxygen variability in the rat. Invest Ophthalmol Vis Sci 41(13): 4275\u20134280","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1789_CR12","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1542\/peds.2004-1309","volume":"115","author":"Darlow","year":"2004","unstructured":"Darlow BA, Hutchinson JL, Henderson-Smart DJ et al. (2004) Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics 115(4): 990\u2013996","journal-title":"Pediatrics"},{"key":"1789_CR13","first-page":"957","volume":"26","author":"Flower","year":"1985","unstructured":"Flower RW, McLeod DS, Lutty GA et al. (1985) Postnatal retinal vascular development of the puppy. Invest Ophthalmol Vis Sci 26(7): 957\u2013968","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1789_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1542\/peds.2004-1413","volume":"116","author":"Good","year":"2005","unstructured":"Good WV, Hardy RJ, Dobson V et al. (2005) The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 116(1): 15\u201323","journal-title":"Pediatrics"},{"key":"1789_CR15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1651-2227.1954.tb15463.x","volume":"43","author":"Gyllensten","year":"1954","unstructured":"Gyllensten LJ, Hellstrom BE (1954) Experimental approach to the pathogenesis of retrolental fibroplasia. I Changes of the eye induced by exposure of newborn mice to concentrated oxygen. Acta Paediatr Suppl 43(100): 131\u2013148","journal-title":"Acta Paediatr Suppl"},{"key":"1789_CR16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","volume":"112","author":"Hellstrom","year":"2003","unstructured":"Hellstrom A, Engstrom E, Hard AL et al. (2003) Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 112(5):1016\u20131020","journal-title":"Pediatrics"},{"key":"1789_CR17","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","volume":"98","author":"Hellstrom","year":"2001","unstructured":"Hellstrom A, Perruzzi C, Ju M et al. (2001) Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A 98(10): 5804\u20135808","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1789_CR18","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/bjo.2007.117283","volume":"91","author":"Holmstrom","year":"2007","unstructured":"Holmstrom G, van Wijngaarden P, Coster DJ, Williams KA (2007) Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies. Br J Ophthalmol 91(12): 1704\u20131708","journal-title":"Br J Ophthalmol"},{"key":"1789_CR19","first-page":"1217","volume":"41","author":"Hughes","year":"2000","unstructured":"Hughes S, Yang H, Chan-Ling T (2000) Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci 41(5): 1217\u20131228","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1789_CR20","first-page":"501","volume":"11","author":"Hutcheson","year":"2005","unstructured":"Hutcheson KA, Paluru PC, Bernstein SL et al. (2005) Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. Mol Vis 11: 501\u2013508","journal-title":"Mol Vis"},{"key":"1789_CR21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2337\/db06-0581","volume":"56","author":"Kita","year":"2007","unstructured":"Kita T, Hata Y, Kano K et al. (2007) Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor. Diabetes 56(1): 231\u2013238","journal-title":"Diabetes"},{"key":"1789_CR22","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1167\/iovs.06-0407","volume":"47","author":"Kociok","year":"2006","unstructured":"Kociok N, Radetzky S, Krohne TU et al. (2006) Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice. Invest Ophthalmol Vis Sci 47(11): 5057\u20135065","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1789_CR23","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/adc.63.10_Spec_No.1151","volume":"63","author":"Kretzer","year":"1988","unstructured":"Kretzer FL, Hittner HM (1988) Retinopathy of prematurity: clinical implications of retinal development. Arch Dis Child 63(10 Spec No): 1151\u20131167","journal-title":"Arch Dis Child"},{"key":"1789_CR24","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1073\/pnas.0702031104","volume":"104","author":"Lofqvist","year":"2007","unstructured":"Lofqvist C, Chen J, Connor KM et al. (2007) IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc Natl Acad Sci U S A 104(25): 10589\u201310594","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1789_CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1203\/01.PDR.0000099772.66376.02","volume":"55","author":"McColm","year":"2004","unstructured":"McColm JR, Cunningham S, Wade J et al. (2004) Hypoxic oxygen fluctuations produce less severe retinopathy than hyperoxic fluctuations in a rat model of retinopathy of prematurity. Pediatr Res 55(1): 107\u2013113","journal-title":"Pediatr Res"},{"key":"1789_CR26","first-page":"474","volume":"43","author":"McLeod","year":"2002","unstructured":"McLeod DS, Taomoto M, Cao J et al. (2002) Localization of VEGF receptor-2 (KDR\/Flk-1) and effects of blocking it in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 43(2): 474\u2013482","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1789_CR27","first-page":"3320","volume":"42","author":"Mino","year":"2001","unstructured":"Mino RP, Spoerri PE, Caballero S et al. (2001) Adenosine receptor antagonists and retinal neovascularization in vivo. Invest Ophthalmol Vis Sci 42(13):3320\u20133324","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1789_CR28","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/emboj\/cdg117","volume":"22","author":"Morita","year":"2003","unstructured":"Morita M, Ohneda O, Yamashita T et al. (2003) HLF\/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J 22(5): 1134\u20131146","journal-title":"EMBO J"},{"key":"1789_CR29","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1203\/PDR.0b013e318165b8d1","volume":"63","author":"Patel","year":"2008","unstructured":"Patel S, Rowe MJ, Winters SA, Ohls RK (2008) Elevated erythropoietin mRNA and protein concentrations in the developing human eye. Pediatr Res 63(4): 394\u2013397","journal-title":"Pediatr Res"},{"key":"1789_CR30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0002-9394(54)90845-4","volume":"38","author":"Patz","year":"1954","unstructured":"Patz A (1954) Oxygen studies in retrolental fibroplasia. IV. Clinical and experimental observations. Am J Ophthalmol 38(3): 291\u2013308","journal-title":"Am J Ophthalmol"},{"key":"1789_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.73.1.1","volume":"73","author":"Phelps","year":"1984","unstructured":"Phelps DL, Rosenbaum AL (1984) Effects of marginal hypoxemia on recovery from oxygen-induced retinopathy in the kitten model. Pediatrics 73(1): 1\u20136","journal-title":"Pediatrics"},{"key":"1789_CR32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","volume":"114","author":"Pierce","year":"1996","unstructured":"Pierce EA, Foley ED, Smith LE (1996) Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 114(10): 1219\u20131228","journal-title":"Arch Ophthalmol"},{"key":"1789_CR33","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","volume":"92","author":"Pierce","year":"1995","unstructured":"Pierce EA, Avery RL, Foley ED et al. (1995) Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 92(3): 905\u2013909","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1789_CR34","doi-asserted-by":"crossref","unstructured":"Quinn GE (2004) Retinal development and the pathophysiology of retinopathy of prematurity. In: Polin RA, Fox WW, Abman SH (eds) Fetal and neonatal physiology. Saunders, Philadelphia, Pennsylvania, pp 1797\u20131802","DOI":"10.1016\/B978-0-7216-9654-6.50178-8"},{"key":"1789_CR35","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0022-3476(97)70031-3","volume":"131","author":"Raju","year":"1997","unstructured":"Raju TN, Langenberg P, Bhutani V, Quinn GE (1997) Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials. J Pediatr 131(6): 844\u2013850","journal-title":"J Pediatr"},{"key":"1789_CR36","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1073\/pnas.93.10.4851","volume":"93","author":"Robinson","year":"1996","unstructured":"Robinson GS, Pierce EA, Rook SL et al. (1996) Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci U S A 93(10): 4851\u20134856","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1789_CR37","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1177\/112067210701700613","volume":"17","author":"Shastry","year":"2007","unstructured":"Shastry BS (2007) Assessment of the contribution of insulin-like growth factor I receptor 3174 G-->A polymorphism to the progression of advanced retinopathy of prematurity. Eur J Ophthalmol 17(6): 950\u2013953","journal-title":"Eur J Ophthalmol"},{"key":"1789_CR38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00417-006-0480-6","volume":"245","author":"Shastry","year":"2007","unstructured":"Shastry BS, Qu X (2007) Lack of association of the VEGF gene promoter (-634 G-->C and -460 C-->T) polymorphism and the risk of advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 245(5): 741\u2013743","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1789_CR39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI17808","volume":"112","author":"Shih","year":"2003","unstructured":"Shih SC, Ju M, Liu N, Smith LE (2003) Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J Clin Invest 112(1): 50\u201357","journal-title":"J Clin Invest"},{"key":"1789_CR40","doi-asserted-by":"crossref","unstructured":"Sibley CP, Boyd RDH (2004) Mechnanisms of transfer across the human placenta. In: Polin RA, Fox WW, Abman SH (eds) Fetal and neonatal physiology. Saunders, Philadelphia, Pennsylvania, pp 111\u2013122","DOI":"10.1016\/B978-0-7216-9654-6.50016-3"},{"key":"1789_CR41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1651-2227.2002.tb00157.x","volume":"91","author":"Smith","year":"2002","unstructured":"Smith LE (2002) Pathogenesis of retinopathy of prematurity. Acta Paediatr Suppl 91(437): 26\u201328","journal-title":"Acta Paediatr Suppl"},{"key":"1789_CR42","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/70963","volume":"5","author":"Smith","year":"1999","unstructured":"Smith LE, Shen W, Perruzzi C et al. (1999) Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5(12): 1390\u20131395","journal-title":"Nat Med"},{"key":"1789_CR43","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1073\/pnas.031252398","volume":"98","author":"Stellmach","year":"2001","unstructured":"Stellmach V, Crawford SE, Zhou W, Bouck N (2001) Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A 98(5): 2593\u20132597","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1789_CR44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1203\/01.PDR.0000153867.80238.E0","volume":"57","author":"Vannay","year":"2005","unstructured":"Vannay A, Dunai G, Banyasz I et al. (2005) Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr Res 57(3): 396\u2013398","journal-title":"Pediatr Res"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-008-1789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-008-1789-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-008-1789-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T21:11:59Z","timestamp":1684703519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-008-1789-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1789"],"URL":"https:\/\/doi.org\/10.1007\/s00347-008-1789-9","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}